The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

61 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of a Potent and Selective GPR4 Antagonist as a Drug Lead for the Treatment of Myocardial Infarction.EBI
Hokkaido University
Structure-activity relationship study of syringolin A as a potential anticancer agent.EBI
Hokkaido University
Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation.EBI
Hokkaido University
Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.EBI
Hokkaido University
Development of a new class of proteasome inhibitors with an epoxyketone warhead: Rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketones.EBI
Hokkaido University
Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates.EBI
Hokkaido University
Lipoxygenase inhibitors derived from marine macroalgae.EBI
Hokkaido University
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.EBI
Hokkaido University
Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action.EBI
Hokkaido University
Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.EBI
Hokkaido University
Substrate-like water soluble lipase inhibitors from Filipendula kamtschatica.EBI
Hokkaido University
Thrombin inhibitors from the freshwater cyanobacterium Anabaena compacta.EBI
Hokkaido University
Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.EBI
Hokkaido University
Synthesis of eudistomin D analogues and its effects on adenosine receptors.EBI
Hokkaido University
2-Aminoresorcinol is a potent alpha-glucosidase inhibitor.EBI
Hokkaido University
Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands.EBI
Hokkaido University
Rational design, synthesis, and characterization of novel inhibitors for human beta1,4-galactosyltransferase.EBI
Hokkaido University
Nucleosides and nucleotides. 200. Reinvestigation of 5'-N-ethylcarboxamidoadenosine derivatives: structure-activity relationships for P(3) purinoceptor-like proteins.EBI
Hokkaido University
Nucleosides and nucleotides. 177. 9-(6,7-dideoxy-beta-D-allo-hept-5- ynofuranosyl)adenine: a selective and potent ligand for P3 purinoceptor-like protein.EBI
Hokkaido University
Nucleosides and nucleotides. 103. 2-Alkynyladenosines: a novel class of selective adenosine A2 receptor agonists with potent antihypertensive effects.EBI
Hokkaido University
Nucleosides and nucleotides. 112. 2-(1-Hexyn-1-yl)adenosine-5'-uronamides: a new entry of selective A2 adenosine receptor agonists with potent antihypertensive activity.EBI
Hokkaido University
A small molecule inhibitor of p53-inducible protein phosphatase PPM1D.EBI
Hokkaido University
Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.EBI
Hokkaido University
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.EBI
Hokkaido University
Synthesis and evaluation of 5-substituted 9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as check point 1 kinase inhibitors.EBI
Hokkaido University
Novel N-methylated 8-oxoisoguanines from Pacific sponges with diverse neuroactivities.EBI
Hokkaido University
An efficient approach to the discovery of potent inhibitors against glycosyltransferases.EBI
Hokkaido University
Efficient synthesis of Hsp90 inhibitor dimers as potential antitumor agents.EBI
Hokkaido University
Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria.EBI
Hokkaido University
Investigation of the bioactive conformation of histamine H3 receptor antagonists by the cyclopropylic strain-based conformational restriction strategy.EBI
Hokkaido University
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.EBI
Hokkaido University
Synthesis and structural and pharmacological properties of cyclopropane-based conformationally restricted analogs of 4-methylhistamine as histamine H3/H4 receptor ligands.EBI
Hokkaido University
Synthesis of hybrid analogues of caffeine and eudistomin D and its affinity for adenosine receptors.EBI
Hokkaido University
Serratezomines D and E, new Lycopodium alkaloids from Lycopodium serratum var. serratum.EBI
Hokkaido University
Synthesis of 1-arylpiperazyl-2-phenylcyclopropanes designed as antidopaminergic agents: cyclopropane-based conformationally restricted analogs of haloperidol.EBI
Hokkaido University
Baicalein, an alpha-glucosidase inhibitor from Scutellaria baicalensis.EBI
Hokkaido University
Mycophenolic acid as a latent agonist of PPARgamma.EBI
Hokkaido University
Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.EBI
Hokkaido University
Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.EBI
Hokkaido University
Synthesis of capuramycin and its analogues via a Ferrier-type I reaction and their biological evaluation.EBI
Hokkaido University
A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.EBI
Hokkaido University
Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5'-O-aminoribosyluridine as MraY inhibitors.EBI
Hokkaido University
Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b).EBI
Hokkaido University
Antimitotic activity and reversal of breast cancer resistance protein-mediated drug resistance by stilbenoids from Bletilla striata.EBI
Hokkaido University
Antimitotic activity of glaupalol-related coumarins from Glaucidium palmatum.EBI
Hokkaido University
Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.EBI
Hokkaido University
Structural requirement of tunicamycin V for MraY inhibition.EBI
Hokkaido University
Malabaricone C as Natural Sphingomyelin Synthase Inhibitor against Diet-Induced Obesity and Its Lipid Metabolism in Mice.EBI
Hokkaido University
Synthesis and biological activity of conformationally restricted analogues of milnacipran: (1S, 2R)-1-phenyl-2-[(R)-1-amino-2-propynyl]-N,N- diethylcyclopropanecarboxamide is a novel class of NMDA receptor channel blocker.EBI
Hokkaido University
Design and synthesis of histamine HEBI
Hokkaido University
Synthesis and biological activity of conformationally restricted analogs of milnacipran: (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxami de, an efficient noncompetitive N-methyl-D-aspartic acid receptor antagonist.EBI
Hokkaido University
Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffold.EBI
Hokkaido University
Conformational restriction approach to β-secretase (BACE1) inhibitors III: effective investigation of the binding mode by combinational use of X-ray analysis, isothermal titration calorimetry and theoretical calculations.EBI
Hokkaido University
Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.EBI
Hokkaido University
Inhibitory effects of metachromins L-Q and its related analogs against receptor tyrosine kinases EGFR and HER2.EBI
Hokkaido University
Spongiacidins A-D, new bromopyrrole alkaloids from hymeniacidon sponge EBI
Hokkaido University
New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6'-homoneplanocin A1.EBI
Hokkaido University
Ability of higenamine and related compounds to enhance glucose uptake in L6 cells.EBI
Hokkaido University
Divergent synthesis of kinase inhibitor derivatives, leading to discovery of selective Gck inhibitors.EBI
Hokkaido University
A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1.BDB
Johns Hopkins University